Deferoxamine mesylate in patients with intracerebral haemorrhage (i-DEF): a multicentre, randomised, placebo-controlled, double-blind phase 2 trialMagdy Selim, Heena Olalde, Karin Collard et al.|The Lancet Neurology|2019Cited by 249
Fostering Resilience: The Role of Team Dynamics in Mitigating Burnout and Enhancing Well-being in the Neurocritical Care Unit (P7-18.010)Vishank Shah, Jose Suarez, Susanne Muehlschlegel et al.|Neurology|2026Cited by 0